A Case of Ketamine-Associated Prolonged Psychosis in the Perioperative Setting: Clinical Course and Management

Kaushal Shah, MD; Sahil Munjal, MD; Greg Noe, MD

Prim Care Companion CNS Disord 2025;27(2):24cr03836

Free Access: Please Log In

This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.

References (9)

Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol. 2009;22(5):588–593. PubMed CrossRef
de Rocquigny G, Dubecq C, Martinez T, et al. Use of ketamine for prehospital pain control on the battlefield: a systematic review. J Trauma Acute Care Surg. 2020;88(1):180–185. PubMed CrossRef
Elsamadicy AA, Charalambous LT, Sergesketter AR, et al. Intraoperative ketamine may increase risk of post-operative delirium after complex spinal fusion for adult deformity correction. J Spine Surg. 2019;5(1):79–87. PubMed CrossRef
Zuccoli ML, Muscella A, Fucile C, et al. Paliperidone for the treatment of ketamine-induced psychosis: a case report. Int J Psychiatry Med. 2014;48(2):103–108. PubMed CrossRef
Mechri A, Saoud M, Khiari G, et al. Hypothèse glutamatergique de la schizophrénie: apports des recherches cliniques sur la kéta [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine]. Encephale. 2001;27(1):53–59. PubMed
Aalto S, Ihalainen J, Hirvonen J, et al. Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl). 2005;182(3):375–383. PubMed CrossRef
Evanoff AB, Baig M, Taylor JB, et al. Ketamine: a practical review for the consultation-liaison psychiatrist. J Acad Consult Liaison Psychiatry. 2023;64(6):521–532.
Radant A, Bowdle T, Cowley D, et al. Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? Neuropsychopharmacol. 1998;19(5):434–444. PubMed CrossRef
Can A, Zanos P, Moaddel R, et al. Effects of ketamine and ketamine metabolites on evoked striatal dopamine release, dopamine receptors, and monoamine transporters. J Pharmacol Exp Ther. 2016;359(1):159–170.